ArticleThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG2025
Pediatric Diabetic Ketoacidosis: Comparing Outcomes of Potassium Acetate Versus Potassium Chloride Using the Two-Bag System.
Article in The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivePediatric diabetic ketoacidosis (DKA) results in dehydration and electrolyte losses, but there is no standardized potassium salt form for repletion. The objective of this research was to assess time to resolution of ketoacidosis in DKA patients comparing different potassium salts in the 2-bag system during an electrolyte shortage.
methodsA retrospective cohort study was performed to review pediatric cases that met the institution's criteria for DKA and were started on the 2-bag system. Patients were identified from use of a DKA order set within the electronic health record. Cases were excluded if a patient received both potassium acetate and chloride, deviated from the active protocol product or were transferred to/from another institution. Data collected included patient demographics, and laboratory values including blood glucose, beta-hydroxybutyrate, venous pH, serum bicarbonate, and serum potassium collected at presentation and then per protocol until resolution of DKA. Initial laboratory values were utilized to determine DKA severity. Statistical analysis included descriptive statistics, Kaplan-Meier analysis for time to resolution of DKA, Wilcoxon rank sum test for continuous non-parametric data, and χ
resultsA total of 124 cases were included: 62 in each cohort. There was a similar number of patients presenting with severe DKA in the potassium acetate group compared with the potassium chloride group (48.4% vs 51.6%). Cases in the potassium acetate group showed a median 48-minute faster time to DKA resolution than the potassium chloride group; this was not a statistically significant difference (p = 0.54). There was a statistically significant difference amongst the median length of stay between the potassium acetate and potassium chloride groups (43.7 hours vs 48.6 hours; p = 0.037). There was no noted mortality in either group.
conclusionsThere were no clinically significant differences in outcomes in pediatric DKA patients when comparing potassium acetate and potassium chloride in the 2-bag system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.